Information between 14th May 2024 - 13th July 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Division Votes |
---|
15 May 2024 - Criminal Justice Bill - View Vote Context Andrew Griffith voted No - in line with the party majority and in line with the House One of 272 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 167 Noes - 275 |
15 May 2024 - Criminal Justice Bill - View Vote Context Andrew Griffith voted No - in line with the party majority and in line with the House One of 260 Conservative No votes vs 1 Conservative Aye votes Tally: Ayes - 17 Noes - 268 |
15 May 2024 - Criminal Justice Bill - View Vote Context Andrew Griffith voted No - in line with the party majority and in line with the House One of 268 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 171 Noes - 272 |
17 May 2024 - Prayers - View Vote Context Andrew Griffith voted No - in line with the party majority and in line with the House One of 21 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 0 Noes - 37 |
21 May 2024 - Digital Markets, Competition and Consumers Bill - View Vote Context Andrew Griffith voted No - in line with the party majority and in line with the House One of 259 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 217 Noes - 268 |
21 May 2024 - High Speed Rail (Crewe - Manchester) Bill (Instruction) (No. 3) - View Vote Context Andrew Griffith voted Aye - in line with the party majority and in line with the House One of 222 Conservative Aye votes vs 5 Conservative No votes Tally: Ayes - 323 Noes - 7 |
23 May 2024 - Finance (No.2) Bill - View Vote Context Andrew Griffith voted Aye - in line with the party majority and in line with the House One of 210 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 215 Noes - 19 |
24 May 2024 - Tribunal and Inquiries - View Vote Context Andrew Griffith voted Aye - in line with the party majority and in line with the House One of 131 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 135 Noes - 10 |
Speeches |
---|
Andrew Griffith speeches from: Oral Answers to Questions
Andrew Griffith contributed 18 speeches (991 words) Wednesday 22nd May 2024 - Commons Chamber Cabinet Office |
Written Answers |
---|
Animal Experiments
Asked by: Patrick Grady (Scottish National Party - Glasgow North) Thursday 16th May 2024 Question to the Department for Environment, Food and Rural Affairs: To ask the Secretary of State for Environment, Food and Rural Affairs, what steps his Department is taking to end the use of LD50 testing on animals. Answered by Mark Spencer The UK supports work to develop New Approach Methodologies which can provide information on chemical hazards and risk assessment without the use of animals. The Veterinary Medicines Directorate (VMD) is the UK regulatory authority for veterinary medicines. The VMD assesses applications submitted by the veterinary pharmaceutical industry in line with national and international regulations and guidance to ensure safe and effective veterinary medicines of good quality are marketed. These requirements may therefore necessitate animal testing either to develop and register new veterinary medicines or for routine product quality control, to ensure the continued quality, safety and efficacy batch to batch. Non-animal tests are not always available. The VMD is committed to phasing out the use of animals for testing purposes where possible, in accordance with the principles of 3Rs (Replacement, Reduction, Refinement). Furthermore, the UK is a signatory to the European Pharmacopoeia (which sets minimum quality standards of medicines) and the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. This commitment to the 3Rs is also enshrined in the UK’s Animals (Scientific Procedures) Act 1986 under which scientific procedures in animals are regulated.
For veterinary medicines significant progress in non-animal testing has been made in recent years, including the possibility of replacing animals by in vitro suitable cell cultures in LD50-type testing methods, and the relevant regulatory quality standards and testing requirements have been revised accordingly for these specific medicines. Many Marketing Authorisation Holders for these specific medicines have already, and more recently, introduced these changes to their authorised medicines, which will reduce the number of animals used. Implementation of new tests for existing products can be a complicated process, requiring extensive validation and it is not always possible to replace all of the existing animal tests with in vitro non-animal replacements for each existing authorised product. The relevant UK Competent Authority for regulation of these medicines will continue to monitor the use of animals in these tests and to recommend use of non-animal tests where possible.
The Minister of State for Science, Research and Innovation (the hon. Member for Arundel and South Downs, Andrew Griffith) recently announced that the Government will publish a plan to accelerate the development, validation and uptake of technologies and methods to reduce reliance on the use of animals in science, which will be published in the summer. He also requested that we double our investment in research to achieve these approaches next year to £20 million across the system in 2024/25. LD50 testing is not required for preclinical development of novel medicines. Quality control testing of some authorised medicines relies on LD50 testing to ensure each batch meets expected quality standards. UK regulators follow the principles of the 3Rs. Significant progress has been made on validating alternative methods which do not use animals, including the possibility of replacing mice by in vitro suitable cell cultures in LD50-type testing methods, and the relevant regulatory quality standards and testing requirements have been revised accordingly for these specific medicines. |
Department Publications - Statistics |
---|
Thursday 16th May 2024
Department for Science, Innovation & Technology Source Page: Space Regulatory Review 2024 Document: (PDF) Found: COPUOS) and UN Office for Disarmament Affairs (ODA) Space Regulatory Review 2024 6 Andrew |
Deposited Papers |
---|
Monday 20th May 2024
Source Page: I. Space Regulatory Review 2024: A targeted review of space regulations. 48p. II. Letter dated 16/05/2024 from Andrew Griffith MP to Greg Clark MP regarding publication of the review. 2p. Document: Ministerial_Letter_on_Space_Regulatory_Review.pdf (PDF) Found: Letter dated 16/05/2024 from Andrew Griffith MP to Greg Clark MP regarding publication of the review. |
Monday 20th May 2024
Source Page: I. Space Regulatory Review 2024: A targeted review of space regulations. 48p. II. Letter dated 16/05/2024 from Andrew Griffith MP to Greg Clark MP regarding publication of the review. 2p. Document: Space_Regulatory_Review_2024-_Report.pdf (PDF) Found: Letter dated 16/05/2024 from Andrew Griffith MP to Greg Clark MP regarding publication of the review. |